Objectives: This study sought to determine, using continuous electrocardiographic monitoring (CEM) pre-transcatheter aortic valve replacement (TAVR), the incidence and type of unknown pre-existing arrhythmic events (AEs) in TAVR candidates, and to evaluate the occurrence and impact of therapeutic changes secondary to the detection of AEs pre-TAVR.
Background: Scarce data exist on the arrhythmic burden of TAVR candidates (pre-procedure).
Methods: This was a prospective study including 106 patients with severe aortic stenosis and no prior permanent pacemaker screened for TAVR. A prolonged (1 week) CEM was implanted within the 3 months pre-TAVR. Following heart team evaluation, 90 patients underwent elective TAVR.
Results: New AEs were detected by CEM in 51 (48.1%) patients, leading to a treatment change in 14 of 51 (27.5%) patients. Atrial fibrillation or tachycardia was detected in 8 of 79 (10.1%) patients without known atrial fibrillation or tachycardia, and nonsustained ventricular arrhythmias were detected in 31 (29.2%) patients. Significant bradyarrhythmias were observed in 22 (20.8%) patients, leading to treatment change and permanent pacemaker in 8 of 22 (36.4%) and 4 of 22 (18.2%) patients, respectively. The detection of bradyarrhythmias increased up to 30% and 47% among those patients with pre-existing first-degree atrioventricular block and right bundle branch block, respectively. Chronic renal failure, higher valve calcification, and left ventricular dysfunction determined (or tended to determine) an increased risk of AEs pre-TAVR (p = 0.028, 0.052, and 0.069, respectively). New onset AEs post-TAVR occurred in 22.1% of patients, and CEM pre-TAVR allowed early arrhythmia diagnosis in one-third of them.
Conclusions: Prolonged CEM in TAVR candidates allowed identification of previously unknown AEs in nearly one-half of the patients, leading to prompt therapeutic measures (pre-TAVR) in about one-fourth of them. Pre-existing conduction disturbances (particularly right bundle branch block) and chronic renal failure were associated with a higher burden of AEs.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jcin.2020.03.031 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Transcatheter versus Surgical Aortic Valve Replacement for Patients With Pulmonary Hypertension.
J Surg Res
December 2024
Division of Cardiac Surgery, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio. Electronic address:
Introduction: Transcatheter aortic valve replacement (TAVR) has become a viable alternative to surgical aortic valve replacement (SAVR) for high-risk patients with aortic stenosis. One such high-risk group is patients with pulmonary hypertension (PH), which is known to increase surgical risk and adversely affect outcomes. This study aims to compare midterm and long-term survival in TAVR and SAVR among patients with PH.
View Article and Find Full Text PDFEnhancing Frailty Assessments for Transcatheter Aortic Valve Replacement Patients Using Structured and Unstructured Data: Real-World Evidence Study.
JMIR Aging
November 2024
Division of Cardiovascular Medicine, College of Medicine, University of Florida, Gainesville, FL, United States.
Article Synopsis
- Transcatheter aortic valve replacement (TAVR) is a treatment for severe aortic stenosis, mainly affecting older adults, requiring accurate frailty assessments for optimal patient selection.* -
- This study analyzed data from 14,000 patients at the University of Florida to improve frailty prediction for TAVR candidates by combining structured electronic health records and unstructured clinical notes, using advanced modeling techniques.* -
- The integrated model significantly outperformed those using only electronic health record data, identifying key frailty predictors, which may enhance patient outcomes in TAVR procedures.*
Impact of multiple comorbidities on long-term mortality in older patients following transcatheter aortic valve replacement.
Heliyon
September 2024
Division of Cardiology, Department of Medicine, School of Medicine, Showa University, Shinagawa, Tokyo, Japan.
Article Synopsis
- The study focuses on older patients undergoing transcatheter aortic valve replacement (TAVR) for severe aortic stenosis, emphasizing the need for better risk assessment tools due to multiple comorbidities.
- Researchers developed a new risk score, the 3C score, based on various cardiac and noncardiac factors to predict two-year all-cause mortality in these patients.
- Results showed that the 3C score was more effective in predicting mortality compared to established scoring systems like the Charlson Comorbidities Index and EuroSCORE II, highlighting its potential for better risk stratification in older adults undergoing TAVR.
Clinical implications of Sokolow-Lyon voltage less than 3.5 mV in patients who have undergone transcatheter aortic valve replacement.
Minerva Cardiol Angiol
October 2024
Department of Cardiology, Tokyo Bay Medical Center, Urayasu, Japan.
Background: Degenerative severe aortic valve stenosis (AS) is increasingly prevalent in the aging population, leading to the adoption of transcatheter aortic valve replacement (TAVR) as a less invasive alternative. While TAVR indications have expanded, the procedure is associated with a substantial incidence of major adverse cardiac events (MACE). The study aims to establish a preoperative risk-stratification system for TAVR candidates based on Sokolow-Lyon voltage (SLV) and other relevant factors.
View Article and Find Full Text PDFImpaired Gastrointestinal Motility and Worsening Heart Failure in Patients Receiving Trans-Catheter Aortic Valve Replacement.
J Clin Med
July 2024
The Second Department of Internal Medicine, University of Toyama, Toyama 930-0194, Japan.
Impaired gastric motility in the form of constipation may often occur in elderly patients with chronic heart failure. Candidates for trans-catheter aortic replacement (TAVR) are of old age and have multiple comorbidities, probably including constipation. However, the clinical implication of a history of constipation in patients receiving TAVR remains unknown.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!